4
H index
3
i10 index
62
Citations
Université de Rennes | 4 H index 3 i10 index 62 Citations RESEARCH PRODUCTION: 5 Articles 19 Papers 1 Chapters RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Diego Useche. | Is cited by: | Cites to: |
Journals with more than one article published | # docs |
---|---|
Small Business Economics | 2 |
Working Papers Series with more than one paper published | # docs |
---|---|
Post-Print / HAL | 15 |
Working Papers / HAL | 3 |
Year ![]() | Title of citing document ![]() |
---|---|
2024 | What Is an Effective Signal in Crowdfunding? Evidence from Expert Researchers and a Meta-Study. (2024). Voshaar, Johannes ; Hornuf, Lars. In: CESifo Working Paper Series. RePEc:ces:ceswps:_11501. Full description at Econpapers || Download paper |
2024 | Formal institutions and cross-border mergers and acquisitions: A systematic literature review and research agenda. (2024). Kumar, Vikas ; Popli, Manish ; Ahsan, Faisal Mohammad. In: International Business Review. RePEc:eee:iburev:v:33:y:2024:i:5:s0969593124000532. Full description at Econpapers || Download paper |
2024 | Global strategy evolution, devolution or revolution: Disruptions to globalization and international business introversion. (2024). Shams, Riad ; Kafouros, Mario ; Vrontis, Demetris ; Thrassou, Alkis. In: Journal of International Management. RePEc:eee:intman:v:30:y:2024:i:5:s1075425324000693. Full description at Econpapers || Download paper |
2025 | Foreign-origin managers and FDI location choice. (2024). Hegarty, Sarah ; Lissoni, Francesco ; Miguelez, Ernest ; Zabetta, Massimiliano Coda. In: Post-Print. RePEc:hal:journl:hal-04783226. Full description at Econpapers || Download paper |
2025 | Financing innovation: The role of patent examination. (2025). Colvin, Christopher ; Billington, Stephen ; Coyle, Christopher. In: QUCEH Working Paper Series. RePEc:zbw:qucehw:309427. Full description at Econpapers || Download paper |
Year ![]() | Title ![]() | Type ![]() | Cited ![]() |
---|---|---|---|
2014 | Are patents signals for the IPO market? An EU–US comparison for the software industry In: Research Policy. [Full Text][Citation analysis] | article | 24 |
2014 | Are patents signals for the IPO market? An EU–US comparison for the software industry.(2014) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 24 | paper | |
2016 | Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies In: Post-Print. [Citation analysis] | paper | 0 |
2015 | Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies.(2015) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
2018 | Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies.(2018) In: NBER Chapters. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | chapter | |
2017 | Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies..(2017) In: NBER Working Papers. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
2016 | Empirical economic analysis of orphan drug legislation impact on innovation In: Post-Print. [Citation analysis] | paper | 0 |
2016 | Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation.(2016) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
2016 | Empirical Economic Analysis of Orphan Drug Innovation In: Post-Print. [Citation analysis] | paper | 0 |
2017 | Empirical Economic Analysis of Orphan Drug Innovation.(2017) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
2016 | Empirical Economic Analysis of Orphan Drug Innovation.(2016) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 0 | paper | |
2020 | Highly-skilled migrants and Cross-border M&A: Firm-level evidence In: Post-Print. [Citation analysis] | paper | 11 |
2017 | Highly-skilled migrants and Cross-border M&A: Firm-level evidence.(2017) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 11 | paper | |
2018 | Highly-skilled migrants and Cross-border M&A: Firm-level evidence.(2018) In: Post-Print. [Citation analysis] This paper has nother version. Agregated cites: 11 | paper | |
2020 | Highly-skilled migrants and Cross-border M&A: Firm-level evidence.(2020) In: Post-Print. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 11 | paper | |
2021 | Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms In: Post-Print. [Full Text][Citation analysis] | paper | 1 |
2021 | Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms.(2021) In: Small Business Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 1 | article | |
2020 | Highly skilled and well connected: Migrant inventors in cross-border M&As In: Post-Print. [Citation analysis] | paper | 17 |
2021 | Highly skilled and well connected: Migrant inventors in cross-border M&As.(2021) In: Working Papers. [Citation analysis] This paper has nother version. Agregated cites: 17 | paper | |
2021 | Highly skilled and well connected: Migrant inventors in cross-border M&As.(2021) In: Working Papers. [Citation analysis] This paper has nother version. Agregated cites: 17 | paper | |
2020 | Highly skilled and well connected: Migrant inventors in cross-border M&As.(2020) In: Journal of International Business Studies. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 17 | article | |
2022 | Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital In: Post-Print. [Citation analysis] | paper | 6 |
2022 | Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital.(2022) In: Small Business Economics. [Full Text][Citation analysis] This paper has nother version. Agregated cites: 6 | article | |
2017 | Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021. In: Working Papers. [Citation analysis] | paper | 0 |
2015 | Patenting Behaviour and the Survival of Newly Listed European Software Firms In: Industry and Innovation. [Full Text][Citation analysis] | article | 3 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team